Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Jaques van Heerden, Joyce Balagadde-Kambugu, Racheal Angom, Rebecca Claire Lusobya, Guillermo Chantada, Laurence Desjardins, Ido Didi Fabian, Trijn Israels, Vivian Paintsil, Laila Hessissen, Mame Ndella Diouf, Moatasem Elayadi, Suzanne D. Turner, Francine Kouya & Jennifer A. Geel. (2023) Evaluating the baseline survival outcomes of the “six Global Initiative for Childhood Cancer index cancers” in Africa. Pediatric Hematology and Oncology 40:3, pages 203-223.
Read now
Read now
Jiou Zhao, Yun Wang, Min Zhou, Jizhao Gao & Yufang Yuan. (2022) The prognostic effect on childhood acute lymphoblastic leukemia of CD34+CD38− expressed in leukemia cells. Hematology 27:1, pages 706-713.
Read now
Read now
Articles from other publishers (14)
N. Aberuyi & S. Rahgozar. (2022) Negative value of CD10−/CD34− immunophenotype in pediatric leukemia and development of a related cell line model for investigating drug resistance. Clinical and Translational Oncology 24:6, pages 1148-1156.
Crossref
Crossref
Munawar Ali Shah, Usman Ahmad, Muhammad Tariq Mahmood, Asad H Ahmad & Muhammad Abu Bakar. (2022) Frequency of CD34 and CD10 Expression in Adolescent and Young Adult Patients Having Precursor B-cell Acute Lymphoblastic Leukemia and Its Correlation With Clinical Outcomes: A Single-Center Study. Cureus.
Crossref
Crossref
Jiajia Xu, Yiyun Wang, Mario A. Gomez-Salazar, Ginny Ching-Yun Hsu, Stefano Negri, Zhao Li, Winters Hardy, Lijun Ding, Bruno Peault & Aaron W. James. (2021) Bone-Forming Perivascular Cells: Cellular Heterogeneity and Use for Tissue Repair. Stem Cells 39:11, pages 1427-1434.
Crossref
Crossref
Narges Aberuyi, Soheila Rahgozar, Elaheh Sadat Ghodousi & Kamran Ghaedi. (2020) Drug Resistance Biomarkers and Their Clinical Applications in Childhood Acute Lymphoblastic Leukemia. Frontiers in Oncology 9.
Crossref
Crossref
Kutay İçöz, Tayyibe Gerçek, Ayşegül Murat, Servet Özcan & Ekrem Ünal. (2019) Capturing B type acute lymphoblastic leukemia cells using two types of antibodies. Biotechnology Progress 35:1, pages e2737.
Crossref
Crossref
Theodore Zwerdling. (2017) Pediatric Acute Lymphoblastic Leukemia. Hematology & Transfusion International Journal 5:3.
Crossref
Crossref
Karina Uehara, Fukino Ikehara, Yasuka Tanabe, Iwao Nakazato, Mariko Oshiro, Morihiko Inamine & Takao Kinjo. (2016) CD10 expression in the neuroendocrine carcinoma component of endometrial mixed carcinoma: association with long survival. Diagnostic Pathology 11:1.
Crossref
Crossref
Lysa B. Minasi, Fernanda R. Godoy, Daniela de M. e Silva, Thaís C. Vieira, Cláudio C. da Silva & Aparecido D. da Cruz. (2013) Applicability of gene expression profile of childhood acute lymphoblastic leukemia at diagnosis and at the end of the induction phase of chemotherapy at a cancer hospital in the state of Goiás (Brazil). Tumor Biology 35:2, pages 1397-1402.
Crossref
Crossref
Viviana M. Rodr?guez-Pardo, Jos? A. Aristizabal, Diana Jaimes, Sandra M. Quijano, Iliana de los Reyes, Mar?a Victoria Herrera, Julio Solano & Jean Paul Vernot. (2013) Mesenchymal stem cells promote leukaemic cells aberrant phenotype from B-cell acute lymphoblastic leukaemia. Hematology/Oncology and Stem Cell Therapy 6:3-4, pages 89-100.
Crossref
Crossref
Eddy Supriyadi Hirshoren, Anjo JP Veerman, Sutaryo S, Ignatius Purwanto, Peter M vdVen & Jacqueline Cloos. (2012) Detection of CD10, CD34 and their combined expression on Childhood Acute Lymphoblastic Leukemia and the association with clinical outcome in Indonesia. journal of Cancer Therapeutics and Research 1:1, pages 20.
Crossref
Crossref
L. S. Arya, K. S. Padmanjali, S. Sazawal, R. Saxena, M. Bhargava, K. P. Kulkarni, M. Adde & I. Magrath. (2011) Childhood T-lineage acute lymphoblastic leukemia: Management and outcome at a tertiary care center in North India. Indian Pediatrics 48:10, pages 785-790.
Crossref
Crossref
Ling-zhen Wang, Li-rong Sun, Yan-xia Zhao & Ling-li Wang. (2011) Preparation and identification of a novel immunomodulator composed of muramyl dipeptide and anti-CD10 monoclonal antibody for treatment of minimal residual disease in acute leukemia children. International Immunopharmacology 11:9, pages 1211-1219.
Crossref
Crossref
Veronique Maguer-Satta, Roger Besançon & Elodie Bachelard-Cascales. (2011) Concise Review: Neutral Endopeptidase (CD10): A Multifaceted Environment Actor in Stem Cells, Physiological Mechanisms, and Cancer. Stem Cells 29:3, pages 389-396.
Crossref
Crossref
Lining Xie, Yoichi Moroi, Gaku Tsuji, Min Liu, Sayaka Hayashida, Masakazu Takahara, Shuji Fukagawa, Satoshi Takeuchi, Baoen Shan, Takeshi Nakahara, Hiroshi Uchi, Takehiko Yokomizo & Masutaka Furue. (2010) CD10-bearing fibroblast inhibits matrigel invasive potency of interleukin-1α-producing squamous cell carcinoma by diminishing substance P levels in the tumor microenvironment. Cancer Science 101:12, pages 2570-2578.
Crossref
Crossref